Clinical Trial Update: Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study update for JKN2501 in Chinese healthy volunteers to evaluate single/multiple ascending doses; study currently recruiting with potential bacterial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Infection
• Respiratory Tract Infection
• Urinary Tract Infection

Drugs mentioned

• JKN2501

Snippet

Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd | Conditions: Bacterial Infections, Urinary Tract Infections | Phase 1 | Status: RECRUITING